12-July-2019: The global renal
denervation market size is expected to reach USD 1.03
billion by 2026, according to a new report by the Grand View Research, Inc. The
market is estimated to register a CAGR of 43.2% during the forecast period.
Growing incidences of hypertension, changing lifestyle, and enduring effect of
renal denervation procedure are the key factors driving market.
Increasing cases of
uncontrolled and drug-resistant hypertension are expected to fuel the demand
for renal denervation. As per the data published in November 2016, by the
Centre for Disease Control and Prevention (CDC), about 75 million people in
U.S. have high blood pressure. High blood pressure increases the risk of stroke
and heart disease, a leading cause of deaths in America. Complications of
hypertension causes 9.4 million deaths each year. Furthermore, hypertension is
responsible for at least 51% of deaths due to stroke and 45% of deaths due to
heart disease.
The renal
denervation market in developed economies, such as U.K., France, and Italy, is
comparatively mature owing to the presence of key companies in these countries
and high demand for such products. Europe commanded the largest share owing to
the rise in number of drug-resistant hypertension cases and technological
advancements.
On the other hand,
developing countries of Asia and Latin America are expected to witness the
fastest growth due to economic growth and increased consumer disposable income.
Further, growing elderly population coupled with high prevalence of diabetes in
these region sis anticipated to propel the region’s development.
In
depth research report on Renal Denervation Market
Further key findings from the report suggest:
·
Ultrasound based renal denervation segment is projected to
register a remarkable CAGR of 43.5% over the forecast period as it overcomes
the limitation of radiofrequency devices
·
Europe led the renal denervation market in 2017 due to high
number of drug-resistant hypertension cases and initiatives, such as R&D,
for the development of effective devices
·
Asian countries are estimated to witness the highest growth
over the forecast period, due to increasing target population coupled with
rising prevalence of diabetes
·
Developing countries of China and India are the major drivers
of the regional market due to populations
·
Key companies in the market are Medtronic PLC; Cardiosonic,
Inc.; Kona Medical, Inc.; Abbott Laboratories; Ablative Solutions, Inc.; Renal
Dynamics; Mercator MedSystems, Inc.; ReCor Medical, Inc.; Boston Scientific
Corp.; and Symple Surgical, Inc.
Grand View Research
has segmented the global renal denervation market on the basis of technology
and region:
Renal Denervation Technology Outlook (Revenue, USD Million,
2014 - 2026)
·
Radiofrequency Based Renal Denervation
·
Ultrasound Based Renal Denervation
·
Micro-Infusion Based Renal Denervation
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment